Maximizing the Potential Public Health Impact of HPV Vaccines: A Focus on Parents

Journal of Adolescent Health

Volumn 40, Issue 2, 2007, Pages 101-103

  Kahn, Jessica A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT HEALTH; EDITORIAL; HUMAN; IMMUNIZATION; PARENTAL ATTITUDE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE;

ADOLESCENT; ATTITUDE TO HEALTH; CHILD; FEMALE; HEALTH PROMOTION; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; SEXUALLY TRANSMITTED DISEASES; UNITED STATES;

EID: 33846459441     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2006.12.002     Document Type: Editorial

References (22)

1. Villa L.L., Costa R.L., Petta C.A., et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6 (2005) 271-278
2. Harper D.M., Franco E.L., Wheeler C.M., et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 367 (2006) 1247-1255
3. Goldie S.J., Grima D., Kohli M., et al. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine. Int J Cancer 106 (2003) 896-904
4. Munoz N., Bosch F.X., Castellsague X., et al. Against which human papillomavirus types shall we vaccinate and screen?. The international perspective. Int J Cancer 111 (2004) 278-285
5. Bergler W.F., and Gotte K. Current advances in the basic research and clinical management of juvenile-onset recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol 257 (2000) 263-269
6. Little J. 35 million teens missing recommended vaccines. AAP News 17 (2000) 81
7. Schaffner W., Brooks D.A., Jenson H.B., et al. Adolescent Vaccination: Bridging from a Strong Childhood Foundation to a Healthy Adulthood (2005), National Foundation for Infectious Diseases, Bethesda, MD
8. Constantine N.A., and Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health 40 (2007) 108-115
9. Zimet G.D., Liddon N., Rosenthal S.L., et al. Chapter 24: psychosocial aspects of vaccine acceptability. Vaccine 24 suppl 3 (2006) S201-S209
10. Kahn J.A., Rosenthal S.L., Hamann T., and Bernstein D.I. Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS 14 (2003) 300-306
11. Olshen E., Woods E.R., Austin S.B., et al. Parental acceptance of the human papillomavirus vaccine. J Adolesc Health 37 (2005) 248-251
12. Dempsey A.F., Zimet G.D., Davis R.L., and Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics 117 (2006) 1486-1493
13. Waller J., Marlow L.A., and Wardle J. Mothers' attitudes towards preventing cervical cancer through human papillomavirus vaccination: a qualitative study. Cancer Epidemiol Biomarkers Prev 15 (2006) 1257-1261
14. Brabin L., Roberts S.A., Farzaneh F., and Kitchener H.C. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine 24 (2006) 3087-3094
15. Davis K., Dickman E.D., Ferris D., and Dias J.K. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis 8 (2004) 188-194
16. Mays R.M., Sturm L.A., and Zimet G.D. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med 58 (2004) 1405-1413
17. Zimet G.D., Mays R.M., Sturm L.A., et al. Parental attitudes about sexually transmitted infection vaccination for their adolescent children. Arch Pediatr Adolesc Med 159 (2005) 132-137
18. Williams D.R. Racial/ethnic variations in women's health: the social embeddedness of health. Am J Public Health 92 (2002) 588-597
19. Freeman H.P., and Wingrove B.K. Excess Cervical Cancer Mortality: A Marker for Low Access to Health Care in Poor Communities (2005), National Cancer Institute, Center to Reduce Cancer Health Disparities, Rockville, MD May. NIH Pub. No. 05-5282
20. Krieger N., Quesenberry Jr. C., Peng T., et al. Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, Black, Hispanic, and White residents of the San Francisco Bay Area, 1988-92 (United States). Cancer Causes Control 10 (1999) 525-537
21. Shui I., Kennedy A., Wooten K., et al. Factors influencing African-American mothers' concerns about immunization safety: a summary of focus group findings. J Natl Med Assoc 97 (2005) 657-666
22. Newman P.A., Duan N., Rudy E.T., and Anton P.A. Challenges for HIV vaccine dissemination and clinical trial recruitment: if we build it, will they come?. AIDs Patient Care STDS 18 (2004) 691-701